SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain ; volume:6 ; number:1 ; day:19 ; month:9 ; year:2023 ; pages:1-15 ; date:12.2023
Communications biology ; 6, Heft 1 (19.9.2023), 1-15, 12.2023
- Creator
-
Jiang, Jiansheng
Boughter, Christopher T.
Ahmad, Javeed
Natarajan, Kannan
Boyd, Lisa F.
Meier-Schellersheim, Martin
Margulies, David H.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s42003-023-05332-w
- URN
-
urn:nbn:de:101:1-2024020211041923952046
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jiang, Jiansheng
- Boughter, Christopher T.
- Ahmad, Javeed
- Natarajan, Kannan
- Boyd, Lisa F.
- Meier-Schellersheim, Martin
- Margulies, David H.
- SpringerLink (Online service)
Other Objects (12)
Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2
Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodies
Neutralizing and enhancing antibodies against SARS-CoV-2
Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein
ELISA detection of SARS-CoV-2 antibodies in saliva
Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodies
Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
Transplacental transfer of SARS-CoV-2 antibodies: a cohort study
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Detection of SARS-CoV-2 antibodies in pediatric kidney transplant patients
Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2
Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2
Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodies
Neutralizing and enhancing antibodies against SARS-CoV-2
Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein
ELISA detection of SARS-CoV-2 antibodies in saliva
Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodies
Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
Transplacental transfer of SARS-CoV-2 antibodies: a cohort study
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Detection of SARS-CoV-2 antibodies in pediatric kidney transplant patients
Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2
Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2
Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodies
Neutralizing and enhancing antibodies against SARS-CoV-2
Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein
ELISA detection of SARS-CoV-2 antibodies in saliva
Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodies
Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
Transplacental transfer of SARS-CoV-2 antibodies: a cohort study
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Detection of SARS-CoV-2 antibodies in pediatric kidney transplant patients